WHO ICTRP trial
Preliminary study on the difference of VHL expression intensity between primary…
ChiCTR2200059890 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200059890 |
|---|---|
| Public title | Preliminary study on the difference of VHL expression intensity between primary tumor mass and metastatic tumor mass of advanced/metastatic renal clear cell carcinoma |
| Scientific title | Preliminary study on the difference of VHL expression intensity between primary tumor mass and metastatic tumor mass of advanced/metastatic renal clear cell carcinoma |
| Primary sponsor | Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Renal cancer |
| Interventions | Advanced/metastatic renal clear cell carcinoma:None |
| Registration date | May 13, 2022 |
| Target size | Advanced/metastatic renal clear cell carcinoma:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: